BudgetState Hospitals / Hospitals
University medical centre · Maastricht
Maastricht UMC+
33 of 68 over the norm
2025, margin 0.5%
sector average 36% (2024)
Maastricht
Locations
- Academisch Ziekenhuis MaastrichtP Debyelaan, 6229HX Maastricht
Wait times
Latest report: 27 October 2026. Over the norm first. The colour measures a wait against the Treeknorm, the position against the other hospitals: position 1 is the shortest.
Over the norm, every fortnight
Waits against the norm, by kind
Treatments
| For | Wait | Position | Median in the Netherlands25th–75th percentile |
|---|---|---|---|
| Total hip replacementOrthopaedics | 240 days | 61 of 61 | 64 days42–90 days |
| Total knee replacementOrthopaedics | 240 days | 60 of 60 | 84 days45–117 days |
| Meniscus or knee ligament surgerySurgery / Orthopaedics | 180 days | 54 of 55 | 50 days33–75 days |
| Tonsil or adenoid removalENT | 107 days | 56 of 63 | 60 days42–82 days |
| Septoplasty (nasal septum surgery)ENT | 101 days | 37 of 61 | 81 days57–146 days |
| Knee arthroscopyOrthopaedics | 90 days | 43 of 46 | 42 days27–63 days |
| VasectomySurgery / Urology | 87 days | 24 of 29 | 43 days28–63 days |
| Cataract surgeryOphthalmology | 83 days | 41 of 56 | 49 days30–84 days |
| Grommets (ear tubes)ENT | 79 days | 53 of 61 | 37 days29–51 days |
| Cardiac ablationCardiology | 60 days | 3 of 10 | 68 days61–88 days |
| Carpal tunnel surgerySurgery / Plastic surgery / Orthopaedics | 59 days | 28 of 37 | 44 days21–59 days |
| Breast reconstructionPlastic surgery | 57 days | 15 of 42 | 79 days52–130 days |
| Coronary artery bypass surgeryCardiothoracic surgery | 55 days | 11 of 12 | 29 days21–46 days |
| Groin hernia repairSurgery | 49 days | 32 of 65 | 49 days28–91 days |
| Peripheral nerve release (incl. carpal tunnel)Neurosurgery | 37 days | 9 of 19 | 46 days32–64 days |
| IVF/ICSIGynaecology | 23 days | 7 of 16 | 27 days8–44 days |
| Coronary angioplasty (PCI)Cardiology | 19 days | 7 of 21 | 26 days14–30 days |
| Gallbladder removalSurgery | 1 days | 1 of 63 | 43 days30–64 days |
| IUI (intrauterine insemination)Gynaecology | 0 days | 1 of 28 | 9 days2–36 days |
Outpatient clinic: first appointment
| For | Wait | Position | Median in the Netherlands25th–75th percentile |
|---|---|---|---|
| AllergyInternal medicine | 290 days | 21 of 23 | 72 days34–143 days |
| Neurology (general)Neurology | 130 days | 58 of 67 | 64 days48–90 days |
| Incontinence in womenGynaecology | 121 days | 40 of 44 | 67 days49–91 days |
| Pain managementAnaesthesiology | 120 days | 53 of 65 | 58 days23–90 days |
| Gastroenterology (general)Gastroenterology | 100 days | 34 of 66 | 98 days50–148 days |
| Gynaecology (general)Gynaecology | 66 days | 32 of 68 | 72 days45–114 days |
| Back problemsOrthopaedics | 60 days | 38 of 42 | 24 days13–42 days |
| EndocrinologyInternal medicine | 60 days | 32 of 49 | 48 days29–67 days |
| Paediatrics (general)Paediatrics | 60 days | 50 of 65 | 35 days21–57 days |
| Hip problemsOrthopaedics | 60 days | 47 of 51 | 14 days7–24 days |
| Foot and ankle problemsOrthopaedics | 60 days | 43 of 49 | 21 days11–50 days |
| Orthopaedics (general)Orthopaedics | 60 days | 55 of 59 | 14 days7–30 days |
| Knee problemsOrthopaedics | 60 days | 48 of 51 | 14 days7–31 days |
| ENT (general)ENT | 40 days | 53 of 66 | 21 days12–30 days |
| ImmunologyInternal medicine | 37 days | 11 of 25 | 38 days29–60 days |
| Vascular surgerySurgery | 35 days | 48 of 62 | 18 days10–30 days |
| Dermatology (general)Dermatology | 30 days | 23 of 66 | 35 days28–70 days |
| Respiratory medicine (general)Respiratory medicine | 30 days | 38 of 68 | 28 days13–42 days |
| Plastic surgery (general)Plastic surgery | 30 days | 40 of 63 | 24 days10–42 days |
| Internal medicine (general)Internal medicine | 30 days | 23 of 68 | 42 days24–61 days |
| Rheumatology (general)Rheumatology | 23 days | 9 of 60 | 47 days29–90 days |
| Fertility problemsGynaecology | 23 days | 7 of 55 | 60 days38–80 days |
| Hearing loss and deafnessENT | 21 days | 16 of 47 | 25 days14–43 days |
| Neurosurgery (general)Neurosurgery | 20 days | 9 of 41 | 42 days22–63 days |
| Oral and maxillofacial surgeryOral and maxillofacial surgery | 20 days | 18 of 57 | 31 days15–59 days |
| Sleep centreOther | 16 days | 3 of 24 | 70 days43–125 days |
| NephrologyInternal medicine | 14 days | 10 of 51 | 33 days19–50 days |
| Geriatric medicineGeriatric medicine | 14 days | 13 of 63 | 28 days16–45 days |
| Cardiology (general)Cardiology | 10 days | 5 of 68 | 28 days16–45 days |
| Groin herniaSurgery | 10 days | 21 of 52 | 17 days7–28 days |
| Surgery (general)Surgery | 10 days | 23 of 66 | 14 days7–27 days |
| Urology (general)Urology | 9 days | 8 of 66 | 32 days20–60 days |
| CataractOphthalmology | 8 days | 13 of 47 | 20 days8–40 days |
| Suspicious skin lesionDermatology | 8 days | 17 of 48 | 13 days7–38 days |
| Medical oncologyInternal medicine | 4 days | 7 of 49 | 9 days6–15 days |
| Paediatric internal medicinePaediatrics | 2 days | 1 of 30 | 30 days17–55 days |
| Breast clinicSurgery | 2 days | 15 of 59 | 3 days2–5 days |
Tests
| For | Wait | Position | Median in the Netherlands25th–75th percentile |
|---|---|---|---|
| Hip or leg MRIRadiology | 20 days | 29 of 64 | 20 days10–33 days |
| Shoulder or arm MRIRadiology | 20 days | 29 of 59 | 20 days13–34 days |
| Back MRIRadiology | 20 days | 29 of 62 | 20 days13–33 days |
| Neck MRIRadiology | 20 days | 28 of 60 | 22 days13–33 days |
| Brain MRIRadiology | 20 days | 28 of 61 | 21 days11–35 days |
| CT scanRadiology | 7 days | 12 of 63 | 14 days9–22 days |
| Bone density scan (DEXA)Radiology | 4 days | 4 of 60 | 18 days12–38 days |
| MammogramRadiology | 2 days | 10 of 62 | 5 days2–10 days |
| X-rayRadiology | 0 days | 1 of 61 | 1 days0–1 days |
| Ultrasound scanRadiology | 0 days | 1 of 66 | 13 days8–17 days |
| GastroscopyGastroenterology | 0 days | 1 of 61 | 26 days15–40 days |
| ColonoscopyGastroenterology | 0 days | 1 of 61 | 28 days17–42 days |
Quality per treatment
Report year 2025, as the hospital reported it, beside the median of all hospitals.
Pancreatic cancer
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Pancreatic head resections (Whipple)number per year | 42 | 44 |
| Severe complications after surgerylower is better | 28.2% | 32.3% |
| Died within 30 days of surgerylower is better | 2.1% | 2.4% |
| Median wait in days until treatmentlower is better | 41 | 32 |
Tonsil or adenoid removal
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Re-operation for bleeding within 14 days (tonsils)lower is better | 3.4% | 2.6% |
| Re-operation for bleeding within 14 days (adenoids)lower is better | 0.0% | 0.0% |
Abdominal aortic aneurysm
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Aortic aneurysm or dissection repairsnumber per year | 104 | 69 |
| Died within 30 days after repair of a ruptured aneurysmlower is better | 28.6% | 24.2% |
| Died within 30 days after repair of an intact aneurysmlower is better | 3.6% | 1.5% |
| Uncomplicated recovery after planned repair (textbook outcome)higher is better | 69.2% | 76.0% |
Stroke
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Stroke patientsnumber per year | 546 | 570 |
| Median minutes from arrival to clot-busting treatmentlower is better | 27.5 | 29 |
Bladder cancer
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Bladder removals for bladder cancernumber per year | 28 | 42 |
| Urologists performing bladder removalsnumber of specialists | 2 | 3 |
| Severe complications within 30 days of surgerylower is better | 13.6% | 15.0% |
| Died within 30 days of surgerylower is better | 0.0% | 0.9% |
Breast implants
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Removed or replaced for a complication within 60 days (reconstruction)lower is better | 0.0% | 2.6% |
| Removed or replaced for a complication within 60 days (cosmetic)lower is better | 0.0% | 0.0% |
| Removed or replaced for a complication, day 61 to 365 (reconstruction)lower is better | 3.1% | 3.3% |
| Removed or replaced for a complication, day 61 to 365 (cosmetic)lower is better | 0.0% | 0.0% |
Breast cancer
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Breast cancer patients operated onnumber per year | 181 | 216 |
| Surgical oncologists treating breast cancernumber of specialists | 6 | 4 |
| Plastic surgeons treating breast cancer patientsnumber of specialists | 5 | 3 |
| Median days from diagnosis to start of treatmentlower is better | 35 | 32 |
Chronic kidney disease and dialysis
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Started dialysis with a working fistula or PD catheterhigher is better | 92.3% | 64.2% |
Bowel cancer
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Colon cancer resectionsnumber per year | 61 | 78 |
| Rectal cancer resectionsnumber per year | 22 | 30 |
| Died within 90 days of rectal surgerylower is better | 0.0% | 0.0% |
| Complicated recovery after colon surgerylower is better | 17.8% | 11.6% |
| Complicated recovery after rectal surgerylower is better | 55.3% | 20.2% |
| Died within 90 days of colon surgerylower is better | 2.8% | 2.2% |
| Median days from diagnosis to treatment (colon)lower is better | 34 | 36.8 |
Diabetes
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Diabetes patients treated by the paediatriciannumber per year | — | 99 |
| Diabetes patients treated by the internistnumber per year | 1,394 | 1,350 |
| Paediatrician: blood sugar on target (HbA1c below 58)higher is better | — | 47.8% |
| Internist: blood sugar on target (HbA1c below 58)higher is better | — | 42.3% |
| Paediatrician: blood sugar far too high (HbA1c above 86)lower is better | — | 5.9% |
| Internist: blood sugar far too high (HbA1c above 86)lower is better | — | 5.3% |
Peripheral arterial disease
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Certified vascular surgeonsnumber of specialists | 7 | 4 |
| Vascular interventional radiologistsnumber of specialists | 9 | 4 |
Gallbladder removal (gallstones)
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Readmitted for a complication within 30 days of surgerylower is better | 4.6% | 2.8% |
Hip fracture
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Hip fractures treatednumber per year | 362 | 293 |
| Mobility score after 3 months, fully mobile before (1 = best)lower is better | 2.5 | 2.6 |
| ADL help needed after 3 months, independent before (0 = none)lower is better | — | 1.3 |
Gynaecological cancer
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Debulking operations for ovarian cancernumber per year | 107 | 60 |
| Operations for endometrial cancernumber per year | 142 | 64 |
| Tumour fully removed at primary debulking (ovary)higher is better | 75.0% | 90.8% |
| Complicated recovery after ovarian debulking (adjusted)lower is better | 7.9% | 6.9% |
| Complicated recovery after keyhole hysterectomy (adjusted)lower is better | 0.0% | 0.0% |
| Died within 30 days of ovarian debulking (adjusted)lower is better | 0.0% | 0.0% |
| Median days from first visit to debulking surgerylower is better | 38 | 35.2 |
Carotid artery surgery
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Carotid artery proceduresnumber per year | 86 | 48 |
| Died within 30 days of the procedurelower is better | 0.4% | 0.8% |
| Bleeding within 30 dayslower is better | 2.6% | 2.5% |
| Neurological event within 30 dayslower is better | 1.3% | 2.0% |
| Uncomplicated recovery (textbook outcome)higher is better | 75.8% | 79.8% |
Slipped disc or spinal stenosis
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Re-operation within 30 dayslower is better | 2.6% | 0.4% |
| Spinal fluid leak during surgerylower is better | 0.0% | 0.3% |
| Deep wound infectionlower is better | 0.0% | 0.0% |
| More muscle weakness right after surgerylower is better | 0.0% | 0.0% |
Hip replacement
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Hip replacementsnumber per year | 158 | 421 |
| Orthopaedic surgeons performing hip revisionsnumber of specialists | 5 | 4 |
| Orthopaedic surgeons placing hip replacementsnumber of specialists | 5 | 5 |
| Deep wound infection within 90 dayslower is better | 1.1% | 0.7% |
| Average hip score gain (OHS) after 12 monthshigher is better | 17.2 | 18.6 |
| Average drop in pain when active after 12 monthshigher is better | 5.0 | 5.8 |
| Revision within 1 year (adjusted)lower is better | 0.6% | 0.9% |
Head and neck cancer
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Re-operation within 30 days of tumour removallower is better | 5.0% | 4.7% |
Cancer care (general)
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Kidney cancer operationsnumber per year | 46 | 54 |
| Colon resectionsnumber per year | 203 | 131 |
| Rectal resectionsnumber per year | 74 | 46 |
| Resections of liver metastasesnumber per year | 36 | 36 |
| Thyroid cancer patients operated onnumber per year | 26 | 18 |
| Gynaecologic oncologists in FTEnumber of specialists | 4.5 | 2.6 |
Knee replacement
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Total knee replacementsnumber per year | 93 | 310 |
| Partial knee replacementsnumber per year | 8 | 79 |
| Orthopaedic surgeons performing knee revisionsnumber of specialists | 4 | 3 |
| Orthopaedic surgeons placing knee replacementsnumber of specialists | 4 | 5 |
| Deep wound infection within 90 dayslower is better | 0.0% | 0.4% |
| Average knee score gain (OKS) after 12 monthshigher is better | 12.0 | 15.3 |
| Average drop in pain when active after 12 monthshigher is better | 3.7 | 4.9 |
| Revision within 3 years (adjusted)lower is better | 1.2% | 1.3% |
Liver surgery
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Liver resectionsnumber per year | 82 | 50 |
| Uncomplicated recovery after liver surgery (adjusted)higher is better | 91.6% | 84.4% |
Lung cancer
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Lung resectionsnumber per year | 58 | 64 |
| Lung cancer patients given curative radiotherapynumber per year | 43 | 174 |
| Died within 90 days of stereotactic radiotherapylower is better | 1.9% | 0.8% |
| Died within 30 days of lung surgerylower is better | 1.0% | 0.9% |
| Complicated recovery after lung surgerylower is better | 10.1% | 12.6% |
| Died within 90 days of chemoradiotherapylower is better | 0.0% | 1.1% |
Melanoma
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| New patients with inoperable melanoma (stage III/IV)number per year | 51 | 67 |
| Alive 1 year after diagnosis (stage III/IV)higher is better | 67.2% | 62.3% |
| Alive 2 years after diagnosis (stage III/IV)higher is better | 41.9% | 48.2% |
Surgery for children
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Groin and scrotal operations in childrennumber per year | 149 | 43 |
| Operations for pyloric stenosisnumber per year | 15 | 15 |
Emergency department
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Patients with severe multiple injuries receivednumber per year | 278 | 33 |
Cataract surgery
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Better sight after surgery (at least 1 line gained)higher is better | 90.9% | 94.5% |
| Within 0.5 dioptre of the target strength after 4-6 weekshigher is better | 77.7% | 77.7% |
Spinal fusion
| Indicator | Maastricht UMC+ | Median in the Netherlands |
|---|---|---|
| Re-operation within 30 dayslower is better | 7.7% | 3.1% |
| Spinal fluid leak during surgerylower is better | 0.0% | 0.7% |
| Deep wound infectionlower is better | 7.7% | 2.0% |
| More muscle weakness right after surgerylower is better | 0.0% | 0.0% |
Annual accounts
Consolidated figures of Academisch Ziekenhuis Maastricht, from its public annual accounts.
| Year | Revenue | Costs | Result | Margin | Equity | Solvency | Cash |
|---|---|---|---|---|---|---|---|
| 2025filed 20 May 2026 | €1.2 bn | €1.2 bn | €6.5 m | 0.5% | €458 m | 40.5% | €246 m |
| 2024filed 14 May 2025 | €1.2 bn | €1.1 bn | €22 m | 1.9% | €451 m | 39.4% | €332 m |
| 2023filed 31 May 2024 | €970 m | €938 m | €29 m | 3.0% | €390 m | 42.5% | €200 m |
| Sector average, University medical centre (2024) | |||||||
| 2024 | — | — | — | 2% | — | 36% | — |
Staff
| Year | Care staff | Sick leave | Long-open vacancies |
|---|---|---|---|
| 2025 | 4,446 | 5.5% | 5 |
| 2024 | 2,978 | 5.8% | 12 |
| 2023 | — | — | — |
Care staff: the average number of people in care. Sick leave: the care staff's sickness absence. Long open: vacancies open for three months or more.
Board and supervision
As the register lists them with the annual accounts for 2025.
Board of directors
- Mertens, Helena Josephina Maria MatheaVoorzitter Raad van Bestuur · since 1 March 2017
- Zwart, Gabriël HermanusPubliekrechtelijk bestuurder · since 1 December 2015
- Zwart, Gabriël HermanusLid Raad van Bestuur · since 1 December 2015
- Mertens, Helena Josephina Maria MatheaPubliekrechtelijk bestuurder · since 1 March 2017
- Maessen, Josephus GregoriusPubliekrechtelijk bestuurder · since 1 January 2025
Supervisory board
- A.M.G.A. de Smet Publiekrechtelijk lid toezichthoudend orgaan · since 1 June 2018
- R.J.M. DassenPubliekrechtelijk lid toezichthoudend orgaan · since 1 October 2019
- C.P.M. MoonenPubliekrechtelijk lid toezichthoudend orgaan · since 1 January 2020
- Thomas Van ElzakkerPubliekrechtelijk lid toezichthoudend orgaan · since 1 August 2022
- Jan-Paul RuttenPubliekrechtelijk lid toezichthoudend orgaan · since 1 June 2023
Proxies and others
- J.L.J. HabetsPrivaatrechtelijk gevolmachtigde · since 19 April 2023
- Liesbeth Inge van de VenAfdelingshoofd ad interim Klinische Farmacie en To · since 1 July 2024
Parking
Maastricht
€1.20 an hour. The first 30 minutes free. Daily maximum €10.
€0.20 per 10 minutes; week card €15.00; spaces at Oncology, Dialysis and A&E free for their patients and visitors.
Read on the hospital's website, 2 November 2026.